Frequently Asked Questions
The market is segmented based on , By Application (Energy and Weight Management, General Health, Bone and Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti- Cancer and Others), End User (Adults, Geriatric, Pregnant Women, Children and Infants), Distribution Channel (Over The Counter (OTC) and Prescribed) – Industry Trends and Forecast to 2031.
.
The Global Multivitamin Tablets Market size was valued at USD 14.20 USD Billion in 2023.
The Global Multivitamin Tablets Market is projected to grow at a CAGR of 6.33% during the forecast period of 2024 to 2031.
The major players operating in the market include Amway (U.S.), Abbott (U.S.), Bayer AG (Germany), Arkopharma (France), Pfizer Inc. (U.S.), Bionova (India), Herbalife International of America, Inc. (U.S.), Nature’s Bounty (U.S.), Ayanda (India), NutraMarks, Inc. (U.S.), Dupont (U.S.), American Health (U.S.), Sona (Ireland), Centurion Laboratories Private Limited (India), Mylan N.V. (U.S.), Dwarkesh Pharmaceuticals Private Limited (India), SaillonPharma (India), Healthy Life Pharma Private Limited (India), HealthKart.com (India), Truebasics.com (India), 21ST Century HealthCare, Inc. (U.S.).
The market report covers data from the U.S., Canada, Mexico, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC), Brazil, Argentina, Rest of South America, U.A.E., Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa (MEA).
